Qianqian Mao

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Mesenchymal Stem Cells

Prognostic Factors

Patient Reported Outcomes

Top Venues

Pediatric investigation

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Zhengping Li, Jie Sun, Zekun Li, Zhenping Chen, Guoqing Liu, Wanru Yao, Xiaoling Cheng, Gang Li, Yingzi Zhen, Di Ai, Yaohan Zhou, Qianqian Mao, Man-Chiu Poon, Runhui Wu
Low-dose immune tolerance induction for severe hemophilia A inhibitor patients: Immunosuppressants are generally not necessary for inhibitor-titer below 200 BU/mL. Pediatric investigation 8 (2) (2024)
Zhengping Li, Jie Sun, Zekun Li, Zhenping Chen, Guoqing Liu, Wanru Yao, Xiaoling Cheng, Gang Li, Yingzi Zhen, Di Ai, Yaohan Zhou, Qianqian Mao, Man-Chiu Poon, Runhui Wu
Low-dose immune tolerance induction for severe hemophilia A inhibitor patients: Immunosuppressants are generally not necessary for inhibitor-titer below 200 BU/mL. Pediatric investigation 8 (2) (2024)
Shuxin Li, Qianqian Mao, Zixuan Zhang, Yuqi Wang, Duoxuan Chen, Zhenwen Chen, Jianyi Lu
Identification of a Five-Gene Panel to Assess Prognosis for Gastric Cancer. BioMed research international 2022 (2022)